tiprankstipranks
Krystal Biotech announces no major objections from CHMP on B-VEC approval
PremiumThe FlyKrystal Biotech announces no major objections from CHMP on B-VEC approval
19d ago
Krystal Biotech Faces Challenges in Scaling VYJUVEK Production Amid Regulatory Hurdles
Premium
Company Announcements
Krystal Biotech Faces Challenges in Scaling VYJUVEK Production Amid Regulatory Hurdles
2M ago
Krystal Biotech Reports Strong Q3 2024 Performance
Premium
Company Announcements
Krystal Biotech Reports Strong Q3 2024 Performance
2M ago
Is KRYS a Buy, Before Earnings?
PremiumPre-EarningsIs KRYS a Buy, Before Earnings?
2M ago
Intellia Therapeutics price target lowered to $64 from $80 at Stifel
Premium
The Fly
Intellia Therapeutics price target lowered to $64 from $80 at Stifel
4M ago
Krystal Biotech price target raised to $220 from $204 at Stifel
Premium
The Fly
Krystal Biotech price target raised to $220 from $204 at Stifel
4M ago
Krystal Biotech could see ‘incremental boost’ on PEARL-1 data, says Stifel
PremiumThe FlyKrystal Biotech could see ‘incremental boost’ on PEARL-1 data, says Stifel
4M ago
Krystal unit Jeune provides efficacy results from PEARL-1 study of COL3
Premium
The Fly
Krystal unit Jeune provides efficacy results from PEARL-1 study of COL3
4M ago
Krystal Biotech price target raised to $206 from $201 at Evercore ISI
Premium
The Fly
Krystal Biotech price target raised to $206 from $201 at Evercore ISI
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100